About
Autifony Therapeutics is a clinical-stage biotechnology company that develops novel ion channel modulators targeting rare and serious central nervous system (CNS) disorders such as Fragile X syndrome and orphan epilepsy syndromes.
Explore Autifony Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.